Giselle Sholler, MD
Beat Childhood Cancer at Atrium Health
10
1
7
N/A
0
8
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (10)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nehal Parikh, MD
Connecticut Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Albert Cornelius, MD
Helen DeVos Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Shared therapeutic areas:
Gustavo Leone
Medical University of South Carolina, Hollings Cancer Center
Shared therapeutic areas:
Jane Robertson
AstraZeneca
Shared therapeutic areas:
Zhaohui Zhu, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
Jean-Olivier ARNAUD, Director
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Mitchell Cairo, MD
New York Medical College
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (10)
Showing 10 of 10 trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma
All 10 trials loaded